Citations 1
Abstract WP112: Predictors of 90-Day Recurrent Stroke in Patients with High-Grade Intracranial Atherosclerotic Stenosis: A subgroup analysis from the BIORISK-ICAS Study
Stretz, Christoph, Lewis, Skylar, Chahien, Dalia, Alam, Shaista , Halabi, Tarek El, Guerrero, Chris, Walsh, Hadley A., Frontera, Jennifer, baker, rich, Nguyen, Thanh, Tunguturi, Ajay, Khan, Muhib, Klaas, James P. , Liebeskind, D, Morsi, Rami, Helenius, Johanna, Khatri, Pooja, Freitas, Joao, Aziz, Yasmin, Rothstein, Aaron, Shu, Liqi , Reda, Mahasen, Tountopoulou, Argyro , Khasawneh, Mohammad W , Klein, Piers, Havenon, Adam de, Almiri, William , Prabhakaran, S, AlMajali, Mohammad, Zaidat, Osama, Qdais, Ahmad Abu, McCullough-Hicks, Margy, Elangovan, Cheran, Sousa, João André, Romoli, Michele, Henninger, Nils, Marto, Joao Pedro, Agarwal, Ayush, Kasab, Sami Al, Yaddanapudi, Sridhara , Krishnaiah, Balaji , Sousa, Diana Aguiar de, Yaghi, Shadi, Henninger, Nils , Sousa, Diana Aguiar de , Henninger, Nils , Aguiar de Sousa, Diana , Khan, Fahad , Stretz, Christoph , Alam, Shaista, Halabi, Tarek El , Sloane, Kelly L , Heldner, Mirjam R. , Antonenko, Kateryna , Baker, Richard, Khan, Muhib , Marrone, Nicole L. , Siegler, James E. , Morsi, Rami Z. , Aziz, Yasmin , Rothstein, Aaron , Reda, Mahasen , Prabhakaran, Shyam , McCullough‐Hicks, Margy , Elangovan, Cheran , Romoli, Michele , Marto, João Pedro , Kasab, Sami Al
Stroke | January 29, 2026 | Volume: 57 | Issue: Suppl_1 | Pages: No page available
Background: High-grade intracranial atherosclerosis (ICAS) is associated with an elevated risk of recurrent ischemic stroke, particularly in patients with severe stenosis (70–99%). Identifying predictors of early recurrence can inform risk stratification and guide treatment strategies. Methods: The Biomarkers and Recurrence Risk in Symptomatic Intracranial Arterial Stenosis (BIORISK-ICAS) study is a multicenter, international, retrospective cohort analysis pooling data from 35 comprehensive stroke centers. We included hospitalized adult patients with symptomatic ICAS, defined as 50–99% stenosis of an intracranial artery (intracranial vertebral, basilar, distal ICA, or M1 MCA), confirmed by vascular imaging and associated with a qualifying ischemic event. Patients with only high-grade stenosis (70-99%) were included in this analysis. The primary outcome was to determine predictors of recurrent ischemic stroke in the territory of the symptomatic artery within 90 days of the index event. Baseline demographic, clinical, and imaging characteristics were recorded. Multivariable Cox proportional hazards regression with stepwise selection (p < 0.1) was used to identify independent predictors of recurrence; model discrimination was assessed using Harrell’s C-statistics. Results: Among 2,050 patients, 1,476 had high-grade (70-99%) symptomatic ICAS. The mean age was 67 ± 12.5 years, and 767 (55%) were male. Most patients were non-Hispanic (90.1%), taking dual antiplatelet therapy (77.8%), and statins (94.5%). Recurrent stroke occurred in 160 patients (10.8%) within 90 days. In multivariable Cox model, independent predictors of recurrence included atrial fibrillation (HR 2.05; 95% CI, 1.26–3.33; p = 0.004), hyperlipidemia (HR 1.57; 95% CI, 1.10–2.24; p = 0.014), diabetes mellitus (HR 1.36; 95% CI, 0.98–1.88; p = 0.064), and home use of dual antiplatelet therapy (HR 1.60; 95% CI, 1.01–2.54; p = 0.043)(Harrell’s C-statistic=0.62). In patients who underwent perfusion(n=402), mistmatch >10seconds were associated with increased recurrence (HR 1.80; 95% CI 0.95-3.38, p=0.07) and atrial fibrillation (HR 2.06: 95% CI 0.03-4.60, p=0.78) though did not reach statistical significance. Conclusion: In this population, diabetes, hyperlipidemia, atrial fibrillation, and prior use of dual antiplatelet therapy were associated with increased risk of 90-day recurrent ischemic stroke. Perfusion imaging may help identify high-risk patients who could benefit from intensified secondary prevention.